Refractory chylothorax: Midodrine as a novel therapeutic option

K. Ur Rehman (London, United Kingdom), L. Ahmed (Madinah, Saudi Arabia), P. Sivakumar (London, United Kingdom)

Source: Virtual Congress 2021 – Clinical problems associated with cough, pleura and respiratory health status

Session: Clinical problems associated with cough, pleura and respiratory health status
Session type: E-poster
Number: 3142

Rating:

You must login to grade this presentation.

Share or cite this content

Citations should be made in the following way:
K. Ur Rehman (London, United Kingdom), L. Ahmed (Madinah, Saudi Arabia), P. Sivakumar (London, United Kingdom). Refractory chylothorax: Midodrine as a novel therapeutic option. 3142

You must login to share this Presentation/Article on Twitter, Facebook, LinkedIn or by email.

Member's Comments

No comment yet.

You must Login to comment this presentation.

Related content which might interest you:

Subcutaneous treprostinil: a new therapeutic approach for idiopathic paediatric pulmonary hypertension Source: Annual Congress 2009 - Pulmonary arterial hypertension Year: 2009
Do we have any alternative therapeutic option beyond antibiotics? Source: Postgraduate course 2021: PG7 - Postgraduate course : Emerging infectious diseases and antimicrobial resistance: diagnostics, treatments, vaccines and other preventive and/or therapeutic interventions Year: 2021
Ideal hydatic cystectomy – a valid therapeutic option Source: Eur Respir J 2006; 28: Suppl. 50, 273s Year: 2006
Anticoagulant treatment for acute pulmonary embolism: a pathophysiology-based clinical approach Source: Eur Respir J 2015; 45: 1142-1149 Year: 2015
Rare iatrogenic cause of chylothorax and management options – poster presentation Source: Eur Respir J 2006; 28: Suppl. 50, 579s Year: 2006
Innovative and unconventional methods for the management of massive hemoptysis: A novel approach Source: Annual Congress 2010 - The broad spectrum of bronchoscopy Year: 2010
An uncommon therapeutic option for a challenging cause of pleural effusion Source: Breathe, 15 (2) e69; 10.1183/20734735.0014-2019 Year: 2019
Causes and management of chylothorax Source: Eur Respir J 2002; 20: Suppl. 38, 605s Year: 2002
Tuberculosis: therapeutic armamentarium Source: ERS Course 2018 - Respiratory Infections Year: 2018
Antibiotics as immunomodulators: a potential pharmacologic approach for ARDS treatment Source: Eur Respir Rev, 30 (162) 210093; 10.1183/16000617.0093-2021 Year: 2021
The MABA approach: a new option to improve bronchodilator therapy Source: Eur Respir J 2013; 42: 885-887 Year: 2013
Therapeutic strategies: what treatment for what patient Source: Annual Congress 2008 - PG12 - Challenges in pulmonary embolism: hot issues and interactive cases (jointly organised with ACCP) Year: 2008
Life-threatening descending mediastinitis: is there space for conservative treatment? Source: International Congress 2017 – CC1 Life-threatening mediastinitis and TB Year: 2017
Chronic cough: a rational approach to investigation and management Source: Eur Respir J 2005; 25: 213-215 Year: 2005
Thymalin as an immunomodulation option in severe COVID-19 Source: Virtual Congress 2021 – COVID - 19 treatments Year: 2021